Skip to main content

Ramiro Maldonado

Assistant Professor of Ophthalmology
Ophthalmology, Vitreoretinal Diseases & Surgery
Duke 2351 Erwin Rd, DUMC 3802, Durham, NC 27710

Research Interests


- Inherited Eye Diseases
- Genetic testing
- Electrophysiology
- Image processing
- Big Data management
- Clinical trials

Selected Grants


A Phase 1/2 Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease.

Clinical TrialPrincipal Investigator · Awarded by Ocugen, Inc. · 2024 - 2029

My Retina Tracker Genetic Testing Study

ResearchPrincipal Investigator · Awarded by Foundation Fighting Blindness, Inc · 2023 - 2025

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated with Rare Disease-Causing Genetic Variants

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2022 - 2023

A Phase 1/2 Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease.

Clinical TrialPrincipal Investigator · Awarded by Ocugen, Inc. · 2024 - 2029

My Retina Tracker Genetic Testing Study

ResearchPrincipal Investigator · Awarded by Foundation Fighting Blindness, Inc · 2023 - 2025

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated with Rare Disease-Causing Genetic Variants

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2022 - 2023

Rate of Progression of PCDH15 Related Retinal Degeneration

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2022 - 2023

Clinical Research Fellowship - David Le

ResearchPrincipal Investigator · Awarded by Baton Rouge Area Foundation · 2022 - 2023

External Relationships


  • Aldeyra Therapeutics
  • PYC Therapeutics
  • ProQR Therapeutics

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.